ArticleScientific reports2015

CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.

Jianfeng Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.